Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Globe Life Industry Stock Comparison

Sell
32

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
18.01
Seasonality Move:
-12.5%
Sell
48

GL
Globe Life

Last Price:
77.63
Seasonality Move:
4%
Sell
32
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.99. The Score for BIS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Globe Life (GL) is a Sell

Is Globe Life a Buy, Sell or Hold?

  • The current Globe Life [GL] share price is $77.55. The Score for GL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • GL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

GL Stock Price Chart

What is Globe Life's stock price today?

  • The Globe Life share price today is $77.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GL is experiencing slight selling pressure.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 3806 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.56 - 20.38) Sell
Bollinger Bands (100): (17.23 - 19.49) Sell

GL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.84 Sell
Relative Strength Index (14 RSI): 42.13 Sell
Chaikin Money Flow: -838997 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.1 - 102.48) Sell
Bollinger Bands (100): (92.06 - 132.64) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.51 Sell
20-day SMA: 19.7 Sell
50-day SMA: 18.52 Sell
200-day SMA: 20.38 Sell
8-day EMA: 19.22 Sell
20-day EMA: 19.39 Sell
50-day EMA: 18.99 Sell
200-day EMA: 19.77 Sell

GL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.56 Sell
20-day SMA: 75.1 Buy
50-day SMA: 102.03 Sell
200-day SMA: 113.15 Sell
8-day EMA: 76.94 Buy
20-day EMA: 80.6 Sell
50-day EMA: 94.85 Sell
200-day EMA: 109.76 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Globe Life Earnings Growth & GL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.18 per share, an increase this year of $1.16 per share, and an increase next year of $1.14 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Globe Life Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):